⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Levi & Korsinsky Urges Regeneron Pharmaceuticals, Inc. (REGN) Shareholders to Act Before Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
globenewswire.com
REGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
accessnewswire.com
EYPT
REGN
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - REGN
globenewswire.com
REGN
REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Pomerantz LLP Notifies Investors of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Canada ICT Market (2026-2031) - Growth Driven by Accelerating Digital Transformation
globenewswire.com
MSFT
AMZN
CSCO
GOOG
IBM
ORCL
CRM
SHOP
LSPD
NOW
PANW
ZS
FTNT
CDNS
SNPS
AMD
NVDA
INTC
MU
AMAT
LRCX
KLAC
TEL
NXPI
ON
ADI
TXN
AEHR
TER
PLTR
AI
SMCI
DELL
HPQ
STX
WDC
REGN
GILD
BIIB
CRSP
XOM
CVX
NEE
DUK
SO
PCG
ETSY
PYPL
QCOM
MRVL
ADSK
CDW
ACN
CSGS
NTAP
VRTX
MRNA
BMY
AMGN
AZN
PFE
JNJ
GOOGL
AAPL
META
NFLX
TSLA
GE
BA
RTX
LMT
GD
HON
CAT
DE
ROKU
WIX
RCL
CCL
NCLH
ATOS